Timely Treatment for COVID-19

Hear an expert overview of emerging options for prevention and outpatient treatment of COVID-19, and learn the rationale for increased federal investment into developing oral antivirals against SARS-CoV-2.

Arthur Kim, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 25, 2021 Expired: August 24, 2022

Review compelling new data on the use of monoclonal antibodies as postexposure prophylaxis for persons exposed to SARS-Cov-2 and as outpatient therapy and inpatient therapy for persons with COVID-19.

Lynora Saxinger, MD, FRCPC, CTropMed Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 10, 2021 Expired: December 9, 2022

Join Arthur Kim, MD, as he discusses exciting data supporting the implementation of oral and IV antiviral medications for postexposure prophylaxis and treatment of SARS-CoV-2.

Arthur Kim, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: February 2, 2022 Expired: February 1, 2023

Join Michael G. Ison, MD, MS, as he reviews the latest recommendations and data supporting currently available outpatient treatment options for COVID-19 and provides a roadmap for implementation of the different strategies.

Michael G. Ison, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 25, 2022 Expired: May 24, 2023

Here’s why we must target our recommendations to treat patients using agents with strong supporting data.

Lynora Saxinger, MD, FRCPC, CTropMed Released: October 8, 2021

Expert review of the rationale, clinical data, and treatment recommendations supporting timeliness in the administration of therapies that act directly against SARS-CoV-2.

Michael G. Ison, MD, MS Arthur Kim, MD Lynora Saxinger, MD, FRCPC, CTropMed Released: May 11, 2022

Gain expert insights on the optimal therapeutic approach for each stage of COVID-19 disease and the guideline recommendations that support timeliness of treatment.

Lynora Saxinger, MD, FRCPC, CTropMed Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 11, 2021 Expired: October 10, 2022

COVID-19 Staging and Progression

Approaching COVID-19 Treatment

Question and Answer Session

Hear expert insights on therapies under evaluation or authorized for the treatment of patients with COVID-19, including which antivirals to use and when, and how to operationalize administration of anti–SARS-CoV-2 monoclonal antibodies in the outpatient setting.

Lynora Saxinger, MD, FRCPC, CTropMed Released: October 11, 2021